Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Novocure Ltd NVCR

Healthcare Medical Devices
NovoCure Limited is a global oncology company. The Company is engaged in the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua for the treatment of solid tumor cancers. Its commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, malignant pleural mesothelioma and... see more

Recent & Breaking News (NDAQ:NVCR)

German Federal Joint Committee Updates Medical Care Directive to include Tumor Treating Fields, establishing National Reimbursement for Optune in Germany

Business Wire March 20, 2020

Novocure Announces Optune Lua(TM) as the Brand Name for the NovoTTF-100L(TM) System

Business Wire March 19, 2020

Preclinical Data Show Tumor Treating Fields Induces Immunogenic Cell Death Resulting in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy

Business Wire March 12, 2020

Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update

Business Wire February 27, 2020

Novocure Announces National Reimbursement in Israel for Optune® in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

Business Wire January 21, 2020

Novocure Announces Fourth Quarter and Full Year 2019 Preliminary Net Revenues and Provides Company Update

Business Wire January 13, 2020

Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer

GlobeNewswire January 9, 2020

Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer

Business Wire January 9, 2020

Novocure to Participate in the 38th Annual J.P. Morgan Healthcare Conference

Business Wire December 26, 2019

SI-BONE Names Jeryl ("Jeri") Hilleman to Board of Directors

GlobeNewswire December 4, 2019

Novocure and the AACR Announce 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program

Business Wire December 2, 2019

Novocure to Participate in the Evercore ISI 2019 HealthCONx Conference

Business Wire November 26, 2019

Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology

Business Wire November 20, 2019

Novocure Reports Third Quarter 2019 Financial Results and Provides Company Update

Business Wire October 31, 2019

Results from STELLAR Trial of Tumor Treating Fields with Chemotherapy in Malignant Pleural Mesothelioma Published in The Lancet Oncology

Business Wire October 16, 2019

Novocure to Report Third Quarter 2019 Financial Results

Business Wire October 1, 2019

Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting

Business Wire September 9, 2019

China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China

Business Wire August 12, 2019

China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China

GlobeNewswire August 12, 2019

Novocure to Participate in Three Upcoming Investor Conferences

Business Wire August 6, 2019